Combining activatable nanodelivery with immunotherapy in a murine breast cancer model

A successful chemotherapy-immunotherapy solid-tumor protocol should accomplish the following goals: debulk large tumors, release tumor antigen for cross-presentation and cross-priming, release cancer-suppressive cytokines and enhance anti-tumor immune cell populations. Thermally-activated drug deliv...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Control Release
Asıl Yazarlar: Kheirolomoom, Azadeh, Silvestrini, Matthew T., Ingham, Elizabeth S., Mahakian, Lisa M., Tam, Sarah M., Tumbale, Spencer K., Foiret, Josquin, Hubbard, Neil E., Borowsky, Alexander D., Ferrara, Katherine W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6660242/
https://ncbi.nlm.nih.gov/pubmed/30978432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.04.008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller